Why Hormel Stock Is Plummeting Today

Hormel Foods (NYSE: HRL) shares declined 12.9% following its fiscal Q3 earnings report, driven by a substantial earnings miss and disappointing forward guidance, despite a slight revenue beat. The company reported adjusted EPS of $0.35, significantly below the $0.41 analyst estimate, while revenue of $3.03 billion slightly exceeded the $2.98 billion forecast. Investors reacted negatively to the projected significant deceleration in organic sales growth to 1-4% for the current quarter and a forecasted dip in adjusted EPS to $0.38-$0.40, signaling that profit recovery will lag into next year.

Analysis

Hormel Foods (HRL) experienced a significant share price decline, falling 12.9% intraday, following the release of its fiscal Q3 results, which presented a concerning outlook despite a minor top-line beat. The company reported sales of $3.03 billion, slightly above the $2.98 billion consensus, supported by a 6% year-over-year increase in organic sales. However, this was completely overshadowed by a substantial earnings miss, with adjusted EPS of $0.35 falling well short of the $0.41 analyst estimate and marking a 5.4% decline from the prior-year period. The primary driver of the negative sentiment was the company's forward guidance. Management projects a sharp deceleration in organic net sales growth to a range of 1% to 4% for the current quarter. Furthermore, the forecast for adjusted EPS between $0.38 and $0.40 indicates a year-over-year profit decline and, critically, management's commentary suggests the company's profit recovery will now lag into the next fiscal year, signaling that underlying margin pressures are persistent and not a transient issue.

Key Decisions for Investors

• Investors should exercise caution, as the market's severe reaction, with the stock down as much as 18.3%, reflects a fundamental reassessment of Hormel's near-term earnings power.
• The forward guidance, which projects a significant deceleration in organic growth to 1-4% and a YoY decline in EPS, warrants a re-evaluation of valuation models and price targets for HRL.
• Monitor future earnings for any evidence of margin stabilization, as management's explicit warning that profit recovery will lag into next year is the key headwind that must be resolved before a bullish thesis can be credibly re-established.